Skip to content

Amphetamine for stroke recovery: a clinical and magnetic resonance imaging study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12247669
Enrollment
71
Registered
2007-03-30
Start date
2000-02-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke Circulatory System Cerebrovascular diseases

Interventions

10 mg amphetamine followed 90 minutes later by one hour physiotherapies, starting five to ten days post stroke, every three to four days for ten drug therapy sessions, versus a matched placebo. Pleas

Sponsors

Sunnybrook Health Sciences Centre (Canada)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Female or male, 30 to 65 year old 2. Ischaemic hemispheric stroke patients with moderate to severe hemiparesis 3. Medically able to participate in a rehabilitation program and expected to survive three months post-stroke 4. Pre-morbid modified Rankin score zero or one 5. Informed consent from patient or substitute decision maker

Exclusion criteria

Exclusion criteria: 1. Brainstem or cerebellar stroke 2. Primary intracerebral haemorrhage 3. Pre-existing neurologic deficit (e.g. from prior stroke) that could interfere with assessments 4. Pregnancy and lactation 5. Prior history of dementia 6. Known hypersensitivity to sympathomimetic amines 7. Unstable cardiac arrhythmia or hypertension not controlled by medication (greater than 170/105 mmHg) 18. History of psychosis or tic disorder 19. Untreated hyperthyroidism 20. Concomitant use of alpha-adrenergic antagonists or agonists 21. Concomitant use of monoamine oxidase inhibitors or use within the preceding 14 days

Design outcomes

Primary

MeasureTime frame
Recovery of hemiparesis measured by the Fugl Meyer Motor Assessment at 13 time points up to three months.

Secondary

MeasureTime frame
All secondary outcomes are measured at baseline, six weeks, and at three months: 1. National Institute of Health Stroke Scale (NIHSS) 2. Western Aphasia Battery (WAB) 3. Sunnybrook Neglect Assessment Procedure (SNAP) 4. Montgomery/Ashberg Depression Rating Scale 5. Apathy Scale 6. Structured Clinical Interview for Diagnostic and Statistical Manual of mental disorders fourth edition (SCID-DSM-IV) 7. Ideomotor Praxis 8. Chedoke-McMaster Stroke Assessment 9. Clinical Outcomes Variable Scale (COVS) 10. Stroke Rehabilitation Assessment of Movement (STREAM) 11. Barthel Index Scale 12. Functional Independence Measure (FIM) 13. Modified Rankin Scale (MRS) 14. Stroke Impact Scale (SIS) 15. Chedoke Arm and Hand Activity Inventory 16. Mini Mental State Examination (MMSE)

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026